AGP Picks
View all

MammoLink adds CureMetrix’s BAC detection to mobile breast screenings

Oct. 30, 2026
MammoLink adds CureMetrix’s BAC detection to mobile breast screenings
By AI, Created 16:33 UTC, Oct 30, 2026, AGP -

MammoLink has added CureMetrix’s cmAngio to its mobile 3D mammography program across 35 Florida counties, giving patients and providers additional clinical insight from routine screening exams. The move expands access to breast imaging and adds AI-powered detection of Breast Arterial Calcifications without extra imaging or workflow changes.

Why it matters: - MammoLink’s move brings AI-supported Breast Arterial Calcification detection into routine breast screening for women across a wide Florida footprint. - The addition can surface extra clinical insight from the same mammogram, without extra radiation, procedures, or added imaging appointments. - The partnership is aimed at underserved, rural, and hard-to-reach women who may have fewer options for regular screening.

What happened: - CureMetrix announced that MammoLink has added cmAngio to its breast imaging program. - MammoLink is a physician-owned provider of mobile 3D mammography services. - The mobile program serves communities, employers, physician offices, and healthcare partners across 35 Florida counties. - The announcement was made on October 30, 2026.

The details: - cmAngio is described as the first and only FDA-cleared solution to detect, quantify, and contextualize Breast Arterial Calcifications, or BAC. - The technology identifies BAC from a routine screening mammogram. - The system is designed to fit into existing mammography workflows. - CureMetrix says the platform is a simple, safe, fast, and effective way to enhance routine breast screening. - MammoLink was founded by fellowship-trained breast imaging radiologist Dr. Ryan Polselli. - Dr. Polselli said the addition lets MammoLink provide more clinical insight from the same exam women are already receiving. - Dr. Polselli said the goal is to improve patient care without adding time, radiation, or complexity to the screening experience. - Kevin Harris, president of CureMetrix, said mobile mammography is a rapidly growing segment of the screening market and serves women who are underserved or hard to reach. - Harris said the partnership turns a mammogram into a 2-for-1 exam.

Between the lines: - The deal fits a broader push to make screening mammography do more than one job at once. - Mobile imaging providers have an advantage when they can add capabilities without disrupting scheduling or requiring new equipment at each site. - The emphasis on BAC suggests a focus on widening the clinical value of breast screening, not just detecting breast cancer.

What's next: - MammoLink will continue deploying mobile breast imaging across its Florida service area with cmAngio included in the screening workflow. - CureMetrix will keep positioning cmAngio as part of its broader AI imaging portfolio for women's health. - Both companies are likely to lean on access, convenience, and workflow simplicity as they expand adoption.

The bottom line: - MammoLink is using AI to make every screening mammogram count for more patients across Florida.

Disclaimer: This article was produced by AGP Wire with the assistance of artificial intelligence based on original source content and has been refined to improve clarity, structure, and readability. This content is provided on an “as is” basis. While care has been taken in its preparation, it may contain inaccuracies or omissions, and readers should consult the original source and independently verify key information where appropriate. This content is for informational purposes only and does not constitute legal, financial, investment, or other professional advice.

Sign up for:

Florida Tech Today

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Florida Tech Today

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.